دورية أكاديمية

Serum Calcitonin Gene-Related Peptide Is Elevated in Patients With Migraine and Ophthalmoplegia.

التفاصيل البيبلوغرافية
العنوان: Serum Calcitonin Gene-Related Peptide Is Elevated in Patients With Migraine and Ophthalmoplegia.
المؤلفون: Takkar A; Departments of Neurology (AT, VL), Internal Medicine (KVAK), Ophthalmology (DK), Radiodiagnosis (PS), Immunopathology (RM, SA), and Community Medicine and School of Public Health (SK), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India ; The Headache and Migraine Clinics (KR), Jaslok and Lilavati Hospitals, Mumbai, India; and Beth Israel Deaconess Medical Center (LC) (LRC), and Department of Neurology (LC), Harvard University, Boston, Massachusetts., Kumar KVA, Katoch D, Singh P, Minz R, Anand S, Kathirvel S, Ravishankar K, Lal V, Caplan LR
المصدر: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society [J Neuroophthalmol] 2023 Sep 01; Vol. 43 (3), pp. 399-405. Date of Electronic Publication: 2022 Oct 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9431308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-5166 (Electronic) Linking ISSN: 10708022 NLM ISO Abbreviation: J Neuroophthalmol Subsets: MEDLINE
أسماء مطبوعة: Publication: <1999->: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: New York, NY : Raven Press, c1994-
مواضيع طبية MeSH: Migraine Disorders*/complications , Migraine Disorders*/diagnosis , Ophthalmoplegia*/diagnosis , Ophthalmoplegic Migraine*/diagnosis, Humans ; Calcitonin Gene-Related Peptide ; Case-Control Studies ; Headache/diagnosis
مستخلص: Background: There is ongoing debate about whether the oculomotor (III), trochlear (IV), or abducens (VI) nerve paresis in patients with migraine is directly attributable to migraine (ophthalmoplegic migraine [OM]) or is due to an inflammatory neuropathy (recurrent painful ophthalmoplegic neuropathy [RPON]). As migraine is associated with elevated serum calcitonin gene-related peptide (CGRP) levels, we studied serum CGRP levels among patients with OM/RPON to determine whether they are elevated during and between attacks. This is the first study assessing CGRP levels in the serum of patients with OM/RPON.
Methods: The aim of this case-control study was to assess serum CGRP levels in patients with ophthalmoplegia and a headache consistent with migraine according to ICHD-3 criteria. Serum CGRP levels were measured during the ictal and interictal phases in 15 patients with OM/RPON and compared with age-matched and sex-matched controls without migraine (12 patients).
Results: The median serum CGRP levels were significantly elevated ( P = 0.021) during the ictal phase (37.2 [36.4, 43.6] ng/L) compared with controls (32.5 [30.1, 37.3] ng/L). Serum CGRP levels during the attack correlated with the total duration of ophthalmoplegia. A CGRP level of 35.5 ng/L in the ictal phase of the attack had a sensitivity of 86.7% and specificity of 75.0% in diagnosing a patient with OM/RPON.
Conclusions: Elevated serum CGRP levels during the ictal phase of OM/RPON favor migraine as the underlying cause of episodic headache with ophthalmoplegia.
Competing Interests: The authors report no conflicts of interest.
(Copyright © 2022 by North American Neuro-Ophthalmology Society.)
References: Carlow TJ. Oculomotor ophthalmoplegic migraine: is it really migraine? J Neuroophthalmol Off J North Am Neuroophthalmol Soc. 2002;22:215–221.
Lal V, Caplan L. Are some ophthalmoplegias migrainous in origin?. Neurol Clin Pract. 2019;9(3):256–262.
Ravishankar K. Ophthalmoplegic migraine: still a diagnostic dilemma? Curr Pain Headache Rep. 2008;12:285–291.
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia Int J Headache. 1988;8(Suppl 7):1–96.
Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.
Lal V, Sahota P, Singh P, Gupta A, Prabhakar S. Ophthalmoplegia with migraine in adults: is it ophthalmoplegic migraine? Headache. 2009;49:838–850.
Ashina M. Migraine. Ropper AH, editor. N Engl J Med. 2020;383:1866–1876.
Dodick DW. CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications. Cephalalgia Int J Headache. 2019;39:445–458.
Lal V. Ophthalmoplegic migraine : past, present and future. Neurol India. 2010;58:15.
Daroff RB. Ophthalmoplegic migraine. Cephalalgia Int J Headache. 2001;21:81.
Chakravarty A, Mukherjee A. Ophthalmoplegic migraine: a critical analysis and a new proposal. Ann Indian Acad Neurol. 2012;15(Suppl 1):S2–6.
Wang Y, Wang XH, Tian MM, Xie CJ, Liu Y, Pan QQ, Lu YN. Ophthalmoplegia starting with a headache circumscribed in a line-shaped area: a subtype of ophthalmoplegic migraine? J Headache Pain. 2014;15:19.
Persistent Focal Enhancement of the Cisternal Segment of Oculomotor Nerve in Ophthalmoplegic Migraine [Internet]. 2020. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874473/ .
Ramón C, Cernuda-Morollón E, Pascual J. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol. 2017;30:281–286.
Goadsby P. Neuropeptides and migraine-a useful biological marker? Cephalalgia Int J Headache. 1995;15:333–334.
Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183–187.
Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain. 2000;86:133–138.
Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G, Trequattrini A, Palumbo R. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia Int J Headache. 1995;15:384–390.
Bharucha DX, Campbell TB, Valencia I, Hardison HH, Kothare SV. MRI findings in pediatric ophthalmoplegic migraine: a case report and literature review. Pediatr Neurol. 2007;37:59–63.
Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012;27:759–766.
المشرفين على المادة: JHB2QIZ69Z (Calcitonin Gene-Related Peptide)
تواريخ الأحداث: Date Created: 20221018 Date Completed: 20230822 Latest Revision: 20230822
رمز التحديث: 20230822
DOI: 10.1097/WNO.0000000000001695
PMID: 36255114
قاعدة البيانات: MEDLINE